AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30552249 — intervention group
Group type: COMPARATOR
Intervention: Standard process (workstation-based store-and-forward teledermatology)
Number of subjects: 0
Study 27265725 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive brivaracetam (BRV) 50–200 mg/day
Number of subjects: 2186
Study 25326180 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic nuclear magnetic resonance (tNMR) with a magnetic flux density of 2.3 mT and a frequency of 85 kHz, 7 sessions
Number of subjects: 94
Study 25326180 — intervention group
Group type: COMPARATOR
Intervention: Standard non-surgical therapy + sham treatments (Control Group)
Number of subjects: 94
Study 25326180 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard non-surgical therapy + tNMR (Treatment Group)
Number of subjects: 94
Study 23591603 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking withdrawal
Number of subjects: 0
Study 23591603 — intervention group
Group type: COMPARATOR
Intervention: Ad libitum smoking
Number of subjects: 0
Study 22104547 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa
Number of subjects: 4038
Study 22104547 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4038
Study 19239400 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection diclofenac sodium 75 mg/ml (test formulation) given as an intradeltoid injection
Number of subjects: 18
Study 19239400 — intervention group
Group type: COMPARATOR
Intervention: Injection diclofenac sodium 75 mg/3 ml (reference formulation) given intragluteally
Number of subjects: 18
Study 16439873 — intervention group
Group type: EXPERIMENTAL
Intervention: 180 mg enfuvirtide, once-daily (QD)
Number of subjects: 37
Study 16439873 — intervention group
Group type: COMPARATOR
Intervention: 90 mg enfuvirtide, twice-daily (BID)
Number of subjects: 37
Study 12616182 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron pretreatment (5 mL of 2 mg in 0.9% saline)
Number of subjects: 150
Study 12616182 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine pretreatment (5 mL of 40 mg in 0.9% saline)
Number of subjects: 150
Study 12616182 — intervention group
Group type: COMPARATOR
Intervention: Saline pretreatment (5 mL of 0.9% saline)
Number of subjects: 150
Study 10632644 — intervention group
Group type: COMPARATOR
Intervention: H. pylori eradication therapy
Number of subjects: 242
Study 9160622 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 148
Study 9160622 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 148
Study 9160622 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study 1474160 — intervention group
Group type: COMPARATOR
Intervention: Fasted state (30-mg OSR tablet every 12 hours)
Number of subjects: 0
Study 1474160 — intervention group
Group type: EXPERIMENTAL
Intervention: Fed state (30-mg OSR tablet every 12 hours)
Number of subjects: 0
Study 6386008 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract (GBE) (40 mg GBE; rökan)
Number of subjects: 79
Study 6386008 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study 30559051 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenalidomide maintenance (10 mg orally on days 1–21 of a 28‐day cycle)
Number of subjects: 1917
Study 30559051 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 1917
Study 30559051 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenalidomide maintenance
Number of subjects: 1917
Study 27873226 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard EQ-5D-5L dimension order (Arm 1)
Number of subjects: 1080
Study 27873226 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomised order between respondents (Arm 2)
Number of subjects: 1080
Study 27873226 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomised within respondents (Arm 3)
Number of subjects: 1080
Study 27873226 — intervention group
Group type: COMPARATOR
Intervention: Scale parameter testing across all arms
Number of subjects: 1080
Study 26581327 — intervention group
Group type: COMPARATOR
Intervention: Delafloxacin 50, 100, 200, 400, 800, 1200, and 1600 mg (single ascending-dose study)
Number of subjects: 52
Study 26581327 — intervention group
Group type: COMPARATOR
Intervention: Delafloxacin 250 mg (single-dose crossover study)
Number of subjects: 52
Study 26581327 — intervention group
Group type: COMPARATOR
Intervention: Delafloxacin 250 mg (parallel group study)
Number of subjects: 52
Study 26581327 — intervention group
Group type: COMPARATOR
Intervention: Delafloxacin 100, 200, 400, 800, 1200 mg once daily for 5 days (multiple ascending-dose study)
Number of subjects: 52
Study 26581327 — intervention group
Group type: EXPERIMENTAL
Intervention: Delafloxacin 900 mg (single-dose, randomized, 3-period crossover study)
Number of subjects: 52
Study 25187580 — intervention group
Group type: EXPERIMENTAL
Intervention: Closing-wedge high tibial osteotomy
Number of subjects: 92
Study 25187580 — intervention group
Group type: COMPARATOR
Intervention: Opening-wedge high tibial osteotomy
Number of subjects: 92
Study 25187580 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 92
Study 22889307 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunarizine
Number of subjects: 68
Study 22889307 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 19208560 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin plus aspirin (LMWH/ASA)
Number of subjects: 88
Study 19208560 — intervention group
Group type: COMPARATOR
Intervention: Aspirin alone (ASA)
Number of subjects: 88
Study 18076814 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-Physician Collaborative Partnership
Number of subjects: 37
Study 15121747 — intervention group
Group type: EXPERIMENTAL
Intervention: EIH subjects at 8.1 mM lactate concentration
Number of subjects: 15
Study 15121747 — intervention group
Group type: EXPERIMENTAL
Intervention: EIH subjects at 41 mM lactate concentration
Number of subjects: 15
Study 15121747 — intervention group
Group type: EXPERIMENTAL
Intervention: EIH and non-EIH subjects combined at 8.1 mM lactate concentration
Number of subjects: 15
Study 15121747 — intervention group
Group type: EXPERIMENTAL
Intervention: EIH and non-EIH subjects combined at 41 mM lactate concentration
Number of subjects: 15
Study 15121747 — intervention group
Group type: COMPARATOR
Intervention: EIH and non-EIH subjects
Number of subjects: 15
Study 11294428 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery with a tourniquet
Number of subjects: 56
Study 11294428 — intervention group
Group type: COMPARATOR
Intervention: Surgery without a tourniquet
Number of subjects: 56
Study 9723147 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg per day)
Number of subjects: 40
Study 9723147 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light (3000 lux, 2 h per day)
Number of subjects: 40
Study 9723147 — intervention group
Group type: COMPARATOR
Intervention: Placebo drug
Number of subjects: 40
Study 9723147 — intervention group
Group type: COMPARATOR
Intervention: Placebo light condition
Number of subjects: 40
Study 8039533 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline carrageenate
Number of subjects: 24
Study 8039533 — intervention group
Group type: COMPARATOR
Intervention: Doxycycline monohydrate
Number of subjects: 24
Study 8039533 — intervention group
Group type: COMPARATOR
Intervention: Combination of omeprazole and doxycycline monohydrate
Number of subjects: 24
Study 3195476 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac counseling plus type A behavioral counseling
Number of subjects: 862
Study 3195476 — intervention group
Group type: COMPARATOR
Intervention: Cardiac counseling
Number of subjects: 862
Study 31813058 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) 2 g/day for 6 months
Number of subjects: 41
Study 31813058 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 41
Study 31813058 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 41
Study 31813058 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 30905018 — intervention group
Group type: EXPERIMENTAL
Intervention: Aeluropus lagopoides ecotypes
Number of subjects: 50
Study 30905018 — intervention group
Group type: COMPARATOR
Intervention: Paspalum vaginatum (control)
Number of subjects: 50
Study 28576901 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided popliteal sciatic (20 mL) and saphenal nerve (8 mL) PNB with ropivacaine 7.5 mg/mL
Number of subjects: 150
Study 28576901 — intervention group
Group type: COMPARATOR
Intervention: Spinal anaesthesia (2 mL) with hyperbaric bupivacaine 5 mg/mL
Number of subjects: 150
Study 25575697 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine-containing tobacco
Number of subjects: 16
Study 25575697 — intervention group
Group type: COMPARATOR
Intervention: Alcohol administration
Number of subjects: 16
Study 25575697 — intervention group
Group type: COMPARATOR
Intervention: Denicotinized tobacco
Number of subjects: 16
Study 23917335 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral rehydration therapy with 2.5 % carbohydrate beverage (group A)
Number of subjects: 6
Study 23917335 — intervention group
Group type: COMPARATOR
Intervention: Control group (water only, group B)
Number of subjects: 6
Study 21403108 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical prognostic model for early prediction of outcome in GBS
Number of subjects: 397
Study 21403108 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical prognostic model validated in an independent cohort of 158 patients with GBS
Number of subjects: 397
Study 19232024 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 45
Study 19232024 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 16531899 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric handgrip exercise (HG) in normoxia
Number of subjects: 24
Study 16531899 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric handgrip exercise (HG) during isocapnic hypoxia
Number of subjects: 24
Study 16531899 — intervention group
Group type: COMPARATOR
Intervention: Isocapnic hypoxia (chemoreflex activation)
Number of subjects: 24
Study 16531899 — intervention group
Group type: EXPERIMENTAL
Intervention: Local circulatory arrest after HG in normoxia
Number of subjects: 24
Study 16531899 — intervention group
Group type: EXPERIMENTAL
Intervention: Local circulatory arrest after HG in hypoxia
Number of subjects: 24
Study 13680386 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (Losec)
Number of subjects: 15
Study 10723972 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic magnesium sulfate with salbutamol
Number of subjects: 35
Study 10723972 — intervention group
Group type: COMPARATOR
Intervention: Normal saline with salbutamol
Number of subjects: 35
Study 9169294 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous sumatriptan
Number of subjects: 19
Study 9169294 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 8466715 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg isradipine twice daily
Number of subjects: 20
Study 8466715 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg nifedipine retard once daily
Number of subjects: 20
Study 3516078 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulised beclomethasone dipropionate
Number of subjects: 29
Study 3516078 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 29
Study 31015270 — intervention group
Group type: EXPERIMENTAL
Intervention: theatre workshop and self-management workshops for children with asthma
Number of subjects: 766
Study 28734623 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin plus Clopidogrel (n=56)
Number of subjects: 113
Study 28734623 — intervention group
Group type: COMPARATOR
Intervention: Aspirin plus Placebo (n=57)
Number of subjects: 113
Study 26571345 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron intake for infants
Number of subjects: 908
Study 26571345 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron intake for toddlers
Number of subjects: 908
Study 26571345 — intervention group
Group type: EXPERIMENTAL
Intervention: Food sources of Fe for infants
Number of subjects: 908
Study 26571345 — intervention group
Group type: EXPERIMENTAL
Intervention: Food sources of Fe for toddlers
Number of subjects: 908
Study 26571345 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-dietary factors associated with Fe intake in infants
Number of subjects: 908
Study 26571345 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-dietary factors associated with Fe intake in toddlers
Number of subjects: 908
Study 25113132 — intervention group
Group type: EXPERIMENTAL
Intervention: HCV notification
Number of subjects: 735
Study 25113132 — intervention group
Group type: EXPERIMENTAL
Intervention: HCV-related notification
Number of subjects: 735
Study 25113132 — intervention group
Group type: EXPERIMENTAL
Intervention: HCV seropositivity testing in prison
Number of subjects: 735
Study 25113132 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic confirmation of HCV infection
Number of subjects: 735
Study 25113132 — intervention group
Group type: EXPERIMENTAL
Intervention: Injecting in prison
Number of subjects: 735
Study 25113132 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid use
Number of subjects: 735
Study 21616975 — intervention group
Group type: EXPERIMENTAL
Intervention: aripiprazole
Number of subjects: 36
Study 21616975 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 36
Study 19113922 — intervention group
Group type: EXPERIMENTAL
Intervention: Phylloquinone (1 mg daily)
Number of subjects: 381
Study 19113922 — intervention group
Group type: EXPERIMENTAL
Intervention: MK4 (45 mg daily)
Number of subjects: 381
Study 19113922 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 381
Study 17724418 — intervention group
Group type: EXPERIMENTAL
Intervention: Reported pain at discharge
Number of subjects: 169
Study 17724418 — intervention group
Group type: COMPARATOR
Intervention: Reported pain vs No pain groups
Number of subjects: 169
Study 17724418 — intervention group
Group type: EXPERIMENTAL
Intervention: Reported pain
Number of subjects: 169
Study 17724418 — intervention group
Group type: EXPERIMENTAL
Intervention: Consistent pain reporting
Number of subjects: 169
Study 17724418 — intervention group
Group type: COMPARATOR
Intervention: No pain reporting
Number of subjects: 169
Study 12544375 — intervention group
Group type: EXPERIMENTAL
Intervention: Reboxetine (8 to 10 mg/d)
Number of subjects: 0
Study 12544375 — intervention group
Group type: EXPERIMENTAL
Intervention: Reboxetine
Number of subjects: 0
Study 12544375 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10890026 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary lycopene
Number of subjects: 946
Study 10890026 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum LDL cholesterol
Number of subjects: 946
Study 10890026 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh tomatoes or tomato juice
Number of subjects: 946
Study 10890026 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooked tomatoes, tomato sauce, or salsa
Number of subjects: 946
Study 10890026 — intervention group
Group type: EXPERIMENTAL
Intervention: Spaghetti with meat sauce
Number of subjects: 946
Study 10890026 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 946
Study 10890026 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index
Number of subjects: 946
Study 9100582 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclic recombinant human growth hormone (20 micrograms/kg.day) plus salmon calcitonin (100 U/day)
Number of subjects: 84
Study 9100582 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclic recombinant human growth hormone (20 micrograms/kg.day) plus placebo
Number of subjects: 84
Study 9100582 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus salmon calcitonin
Number of subjects: 84
Study 9100582 — intervention group
Group type: COMPARATOR
Intervention: Combined placebo
Number of subjects: 84
Study 9100582 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclic recombinant human growth hormone plus placebo
Number of subjects: 84
Study 9100582 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclic recombinant human growth hormone plus salmon calcitonin
Number of subjects: 84
Study 8386794 — intervention group
Group type: EXPERIMENTAL
Intervention: Lomefloxacin (400 mg orally 2‐6 h before surgery)
Number of subjects: 51
Study 8386794 — intervention group
Group type: COMPARATOR
Intervention: Cefuroxime (1.5 g intravenously 30‐90 min before surgery)
Number of subjects: 51
Study 2948534 — intervention group
Group type: COMPARATOR
Intervention: AH23848 (70 mg orally)
Number of subjects: 40
Study 2948534 — intervention group
Group type: COMPARATOR
Intervention: AH23848 (70 mg three times a day for seven days)
Number of subjects: 40
Study 2948534 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 29911511 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) sessions, three interviews per subject, performed monthly over a 3-month period
Number of subjects: 28
Study 29911511 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) sessions
Number of subjects: 28
Study 30176974 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 94
Study 30176974 — intervention group
Group type: COMPARATOR
Intervention: Upright seated position
Number of subjects: 94
Study 27177424 — intervention group
Group type: EXPERIMENTAL
Intervention: hfCPR (human feedback)
Number of subjects: 326
Study 27177424 — intervention group
Group type: EXPERIMENTAL
Intervention: mfCPR (mechanical feedback)
Number of subjects: 326
Study 27177424 — intervention group
Group type: COMPARATOR
Intervention: sCPR (standard BLS without feedback)
Number of subjects: 326
Study 24503341 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-minute educational program
Number of subjects: 877
Study 24503341 — intervention group
Group type: COMPARATOR
Intervention: Educational brochure
Number of subjects: 877
Study 22658778 — intervention group
Group type: EXPERIMENTAL
Intervention: Infohealth mobile phone-based intervention
Number of subjects: 700
Study 20863951 — intervention group
Group type: EXPERIMENTAL
Intervention: varespladib 500 mg daily plus atorvastatin 80 mg daily
Number of subjects: 625
Study 20863951 — intervention group
Group type: COMPARATOR
Intervention: placebo plus atorvastatin 80 mg daily
Number of subjects: 625
Study 18226046 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral glucose tolerance test (OGTT) at baseline and after 6 years
Number of subjects: 910
Study 18226046 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight increase, waist-to-hip ratio, indices of insulin resistance and beta-cell function
Number of subjects: 910
Study 15944845 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with type 2 diabetes
Number of subjects: 209
Study 15944845 — intervention group
Group type: COMPARATOR
Intervention: Non-diabetic subjects
Number of subjects: 209
Study 15944845 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined data of both groups
Number of subjects: 209
Study 15944845 — intervention group
Group type: EXPERIMENTAL
Intervention: C-reactive protein adjusted for BMI
Number of subjects: 209
Study 12883404 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 45
Study 12883404 — intervention group
Group type: COMPARATOR
Intervention: Desflurane
Number of subjects: 45
Study 12883404 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 45
Study 10484538 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-radiation therapy after balloon angioplasty
Number of subjects: 21
Study 10484538 — intervention group
Group type: COMPARATOR
Intervention: Control (edges of the treated segment)
Number of subjects: 21
Study 8934779 — intervention group
Group type: EXPERIMENTAL
Intervention: Converted speech rate (1.6 times slower)
Number of subjects: 21
Study 8934779 — intervention group
Group type: COMPARATOR
Intervention: Original speech rate
Number of subjects: 21
Study 8934779 — intervention group
Group type: EXPERIMENTAL
Intervention: Converted speech rate
Number of subjects: 21
Study 1860132 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral diclofenac (50 mg to 100 mg)
Number of subjects: 107
Study 1860132 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study 6311477 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (10, 20, or 40 mg/day for 4 wk each)
Number of subjects: 34
Study 6311477 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 30325018 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (12 weeks)
Number of subjects: 9
Study 30325018 — intervention group
Group type: COMPARATOR
Intervention: One-legged knee-extensor exercise (single bout)
Number of subjects: 9
Study 30325018 — intervention group
Group type: COMPARATOR
Intervention: Single bout of exercise
Number of subjects: 9
Study 28987245 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation classes (four 90-min sessions)
Number of subjects: 80
Study 28987245 — intervention group
Group type: COMPARATOR
Intervention: Routine pregnancy care
Number of subjects: 80
Study 27491531 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided internet cognitive-behavioural therapy (ICBT)
Number of subjects: 132
Study 27491531 — intervention group
Group type: EXPERIMENTAL
Intervention: Unguided internet cognitive-behavioural therapy (U-ICBT)
Number of subjects: 132
Study 27491531 — intervention group
Group type: EXPERIMENTAL
Intervention: Unguided bibliotherapy
Number of subjects: 132
Study 27491531 — intervention group
Group type: COMPARATOR
Intervention: Control condition (waiting list)
Number of subjects: 132
Study 24704281 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth-borne SARME (n = 15)
Number of subjects: 30
Study 24704281 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone-borne SARME (n = 15)
Number of subjects: 30
Study 24704281 — intervention group
Group type: COMPARATOR
Intervention: Tooth-borne SARME (n = 13)
Number of subjects: 30
Study 22971356 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate care clinics for diabetes (ICCD)
Number of subjects: 1997
Study 22971356 — intervention group
Group type: COMPARATOR
Intervention: Standard GP care (Control)
Number of subjects: 1997
Study 19389335 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 104
Study 19389335 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 104